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96 J.-P. Trezzi et al. /MethodsX 4 (2017) 95–103A B S T R A C TMetabolome analyses of body ﬂuids [35_TD$DIFF] are challenging due pre-analytical variations, such as pre-processing delay
and temperature, and constant dynamical changes of biochemical processes within the samples. Therefore,
proper sample handling starting from the time of collection up to the analysis is crucial to obtain high quality
samples and reproducible results. A metabolomics analysis is divided into 4 main steps: 1) Sample collection, 2)
Metabolite extraction, 3) Data acquisition and 4) Data analysis.
Here, we describe a protocol for gas chromatography coupled to mass spectrometry (GC–MS) based metabolic
analysis for biological matrices, especially body ﬂuids. This protocol can be applied on blood serum/plasma, saliva
and cerebrospinal ﬂuid (CSF) samples of humans and other vertebrates. It covers sample collection, sample pre-
processing, metabolite extraction, GC–MS measurement and guidelines for the subsequent data analysis.
Advantages of this protocol include:
 Robust and reproducible metabolomics results, taking into account pre-analytical variations that may occur
during the sampling process
 Small sample volume required
 Rapid and cost-effective processing of biological samples
 Logistic regression based determination of biomarker signatures for in-depth data analysis
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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Materials 50mL body ﬂuid (for analysis in triplicates), such as plasma, serum, saliva or CSF (fresh or stored at
80 C) Methanol (High purity, LC–MS grade) at 20 C
 Internal standard [U-13C]Ribitol (Omicron Biochemicals, ALD-062)
 Sample collection tubes, such as sterile collection tubes (for CSF and saliva), EDTA and serum-
separating tubes (for blood) Wet ice
 Methoxyamine hydrochloride 98% (Sigma-Aldrich, 226904)
 Pyridine 99.8% (Sigma-Aldrich, 270970)
 N-methyl-N-trimethylsilyl-triﬂuoroacetamide (Macherey-Nagel, 701270.110)
 Alkane standard mixture for performance tests of GC-systems (Sigma-Aldrich, 68281-10ml-F)
 GC glass vials with micro insert (gastight) 5–250mL (various suppliers)
 (Magnetic) caps for GC glass vials (various suppliers)
All aqueous solutions used throughout this protocol should be prepared with MilliQ or deionized
water (18.2MV cm, <3ppb TOC).
Note: The proper selection of the collection tubes is highly relevant for GC–MSbasedmetabolomics
analyses. In Section Choice of collection tubes we review and recommend several types of collection
tubes for the different body ﬂuid types. In general, we recommend the use of sterile tubes to reduce
the risk of sample contamination.
Equipment Reaction tube centrifuge, such as Eppendorf 5424R
 Refrigerated rotary vacuum evaporator, such as CentriVap Concentrator refrigerated (Labconco)
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 GC–MS instrument, such as Agilent 7890A GC System – Agilent 5975C inert XL MSD
 Autosampler, such as Gerstel Multi Purpose Sampler for automated derivatization and injection
 Agilent J [36_TD$DIFF]&W DB-35MS, 30m0.25mm0.25mm (L I.D.ﬁlm thickness) + 5m Duraguard or
different brand
Disclaimer
All protocols using biological material involving humans must be reviewed and approved by an
ethical board and must be carried out in accordance with “The Code of Ethics of the World Medical
Association” (Declaration of Helsinki).
Choice of collection tubes
To get the best outcome, the choice of the correct sampling device for sample collection is crucial.
Sampling devices may contain additives that are interacting with the analytes of interest and might
even lead to non-reproducible results. In addition, not every collection device is suitable for all body
ﬂuids, and body ﬂuid-speciﬁc collection devices must be used. We recommend using collection tubes
without additives or containing additives (e.g. EDTA) that do not interfere with endogenous
metabolite concentrations. For saliva and CSF the sampling can be done into sterile collection tubes
without additives and stored at 80 C after centrifugation.
For serum collection via venipuncture, plain collection tubes cannot be used. For serum, the blood
is sampled into serum-separating tubes (SSTs) containing a gel separating the serum from blood cells.
The clotting step is important and is usually done at RT for 30min depending on the type of serum tube
and the coagulation enhancer added. After centrifugation a physical barrier between serum and blood
cells is formed. Serum can then be easily separated from the blood cells after centrifugation and used
for metabolome analyses. Due to pre-analytical variations (e.g. temperature or pre-centrifugation
delay), the metabolic proﬁle can change very rapidly. Thermolabile and phosphorylated compounds
are sensitive to pre-analytical variations (e.g. spontaneous biochemical reactions) which exacerbates
metabolite analysis. It is therefore recommended to keep the samples at RT for the absolute necessary
minimum period of time.
For plasma, anti-coagulating substances are used to prevent clotting of the blood sample. There are
many options available, such as citrate and ethylenediaminetetraacetic acid (EDTA). In general,
anticoagulants interfere with endogenous blood clotting processes by binding calcium ions from
coagulation proteins. Thereby, clotting reactions are inhibited. We recommend using EDTA
vacutainers as EDTA is not interfering with endogenous metabolites in contrast to other anti-
coagulating substances such as citrate. Whereas citrate from collection tubes superimposes
endogenous citrate, EDTA does not interfere with endogenous metabolites. Citrate and EDTA will
be detected by GC–MS and may lead to a chromatographically overloaded peak causing analytical
problems. However, this is not problematic under the described conditions due to chromatographic
separation of these compounds and endogenous compounds.
The sampling procedure must be performed in a standardized manner to reduce variability
emanating from circadian rhythm or other pre-analytical variations. In particular blood drawing
shows a high variability during the course of the day. Thereby, it is crucial to standardize the sample
collection procedures to speciﬁc day times and tomonitor the exact sampling times for each donor. In
general, blood collection should be performed after an overnight fasting of at least 8 h to reduce diet-
related interactions in the metabolome.
Sample pre-processing
Beforemetabolite extraction, the body ﬂuid has to be separated from undesired biological material
such as cells, debris or particles. Sample pre-processing is thereby separating the majority of the cells
that would otherwise result in further biochemical reactions in a biological sample over time.
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processes that emanate from the remaining cells.
Additionally, to avoid pre-analytical variations, the processing should be donewithin 1h following
the sample collection and the samples should be stored on ice (4 C) during this period [1]. Pre-
analytical variation, such as the storage temperature or the pre-centrifugation delay can highly impact
the sample quality and should be standardized andmonitored. The sample pre-processing procedures
for the individual body ﬂuids are as follows: For CSF samples, centrifuge the tubes at 2000 g, 4 C for 10min [2].
 For serum, allow the samples to clot for 30min at RT (in accordance with the collection tube
manufacturer’s guide) and then centrifuge at 2000 g, 4 C for 10min [3]. For plasma, centrifuge the tubes at 2000 g, 4 C for 20min [3].
 For saliva samples, centrifuge the tubes at 12,000 g, 4 C for 10min. Due to the highmucus content
and large food debris that can be present in freshly sampled saliva, we recommend a higher
centrifugation speed as for the other body ﬂuids [4] .
After sample pre-processing, the supernatant is transferred in new tubes. We recommend using
cryotubes without additives in order to enable optimal storage conditions for metabolomics studies.
The samples can either be used directly for the metabolite extraction or can be stored at 80 C until
further sample processing.
Metabolite extraction
The samples should always be allowed to thaw at 4 C that can either be done on wet ice or in
cooling racks. The samples should be kept at low temperatures as biochemical reactions can occur at
higher temperatureswhich signiﬁcantly reduces sample quality. After thawing, the samples should be
processed as quickly as possible to avoid changes in the sample quality due to pre-analytical
variations, such as temperature and time.
The identical volume is removed three times from each sample and processed in parallel to assess
the performance of the analytical procedure. The metabolomics standards initiative recommends
favoring biological replicates over technical replicates [5]. However, in addition we recommend
sample extraction in technical triplicates to better account for variation in the extraction and
analysis process. [37_TD$DIFF] An integral part of metabolite extraction is the quenching step. Quenching is the
process by which all biochemical processes within the sample are suppressed. In addition, all
proteins within the sample are precipitated. Within this protocol, this step is performed by a
methanol water mixture.
The metabolite extraction procedures for the individual body ﬂuids are as follows: The extraction
ﬂuid has to be prepared in advance and stored at 20 C until metabolite extraction. Note: Additional
internal standards can be used for monitoring of different substance classes. This protocol has been
adapted from the plasma metabolite extraction and analysis protocol described by Jiye et al. [6].
Preparation of extraction ﬂuid (8:1 MeOH/H2O [38_TD$DIFF] IS mixture):
1. Prepare the internal standard solution (H2O+ IS) by diluting [U13C]Ribitol with MilliQ water to
obtain a concentration of 45mg/mL
2. Mix 8 volumes of methanol (MeOH) with 1 volume of the internal standard solution (c [39_TD$DIFF]([U13C]
Ribitol) = 45mg/mL) to obtain the ﬁnal extraction ﬂuid (pre-chilled at 20 C) for metabolite
extraction (c([U13C]Ribitol) = 5mg/mL)
Metabolite extraction (in triplicate for each sample):
1. Mix 10mL of either plasma, serum, CSF or saliva with 90mL extraction ﬂuid (20 C) in a 1.5-ml-
reaction tube for quenching. We recommend to aliquot the extraction ﬂuid before adding the
samples and to keep all samples on ice.2. Vortex thoroughly
3. Shake for 5min on Thermomixer at 1400 rpm, 4 C
4. Centrifuge for 5min at 16,000 g, 4 C
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the pellet for protein extraction if applicable (see below)6. Dry supernatant in a refrigerated rotary vacuum evaporator at 4 C for a minimum of 1h.
Important: Make sure the samples are completely dry7. Before taking out the vials, allow the refrigerated rotary vacuum evaporator to warm up to RT for
30min to prevent water condensation in vials. This avoids problems during derivatizationwhich is
highly sensitive to humidity.8. Tightly cap vials and store at 80 C until GC–MS measurement
Optional extension to proteomics analyses:
After step 4, the supernatant contains polar metabolites and is used for subsequent metabolomics
analysis. The pellet contains DNA, RNA and proteins, and can be applied for subsequent proteomics
analysis.[40_TD$DIFF] For this, reaction tubes are dried in a refrigerated rotary vacuum evaporator at 4 C and
stored at 80 C until proteomics analysis.
Derivatization and GC–MS analysis
Within this protocol, the GC–MS measurement includes a 2-step derivatization of the sample.
Most of the metabolites present in body ﬂuids contain polar functional groups, such as hydroxyl,
carboxyl, thiol, phosphate or amine groups. Gas chromatography only separates gaseous compounds
and therefore requires chemical derivatization to increase volatility of mostly polar metabolites.
In GC–MS-based metabolomics analyses, a 2-step derivatization is often applied by using
methoxyamine hydrochloride andN-methyl-N-trimethylsilyl-triﬂouroacetamide (MSTFA) [41_TD$DIFF] 7,8]. In the
ﬁrst step, methoxyamine hydrochloride is used to reduce the chromatographic complexity of the
samples, e.g. hexoses are ﬁxed in open-chain form to avoid the detection of anomers. In the second
step, silylationwithMSTFA substitutes active protons of polar functional groups (e.g. hydroxyl groups)
with trimethyl-silyl groups to increase metabolite volatility and metabolite stability.
We recommend using an automated sample derivatization to improve precision and accuracy of
the derivatization step. After derivatization, the samples can be measured by GC–MS. The following
GC–MS method protocol is optimized for the GC–MS measurement of the generated samples (see
above):
Derivatization
Perform automated sample derivatization using an autosampler and sample preparation robot. Dissolve dried samples in 15mL pyridine, containing 20mg/mL methoxyamine hydrochloride
 Incubate at 40 C for 90min under shaking
 Add 15mL N-methyl-N-trimethylsilyl-triﬂouroacetamide (MSTFA)
 Incubate at 40 C for 30min under continuous shaking
GC–MS analysis
GC–MS analysis is performed by using a gas chromatograph coupled to amass spectrometer with a
quadrupole analyzer and an electron ionization source, such as an Agilent 7890A GC coupled to an
Agilent 5975C inert XL Mass Selective Detector (Agilent Technologies, Germany). The gas
chromatograph is equipped with a 30m DB-35MS capillary column+5m DuraGuard capillary in
front of the analytical column (Agilent J[36_TD$DIFF]&WGC Column). We recommend using a pre-column in front
of the analytical column to preserve optimal chromatographic conditions. In addition, as (non-
volatile) impurities can decrease chromatographic selectivity, a pre-column enables the preservation
of the full length of the analytical column after column trimming.
The GC–MS measurement is performed in accordance to the following GC parameters (optimized
for the before mentioned Agilent GC–MS system):
100 J.-P. Trezzi et al. /MethodsX 4 (2017) 95–1031. Split/Splitless inlet
 Inlet temperature 270 C
Split ratio 10:1[42_TD$DIFF] .[43_TD$DIFF] . Injection volume: 1mL
[43_TD$DIFF] . Carrier gas: Helium
[43_TD$DIFF]5. Flow rate: 1.2mL/min (constant)
[44_TD$DIFF]6. GC oven
 Temperature program: 90 C for 1min and increased to 320 C at 15 C/min, then held at that
temperature for 8min. Total run time for each sample is 24.3min.Mass selective detector (MSD) parameters[45_TD$DIFF]7.
 Temperature settings
 Transfer line 280 C
[46_TD$DIFF] Ion source 230 C
Quadrupole 150 C[47_TD$DIFF]8.[48_TD$DIFF]9. Electron ionization at 70eV
[49_TD$DIFF]10. Full scan mass spectra from m/z 70 to 700
[50_TD$DIFF]11. Minimum scan rate: 4 scans/sGC–MS raw data analysis
Deconvolution of mass spectra, peak picking, integration, and retention index calibration are
performed using theMetaboliteDetector software Version 2.5 or higher [51_TD$DIFF] 9]. Compounds are identiﬁed
using a mass spectral reference library.
The following deconvolution settings are applied: Peak threshold: 5
 Minimum peak height: 5
 Bins per scan: 10
 Deconvolution width: 5 scans
 No baseline adjustment
 Minimum 15 peaks per spectrum
 No minimum required base peak intensity
Retention index calibration is based on a C10–C40 even n-alkanemixture. For detailed information
on the use of the different settings, please visit http://md.tu-bs.de/.
GC–MS quality assurance
To increase the quality of the GC–MS measurement, the following points should be carefully
considered:
1. Extraction blanks. Extraction blanks are blanks for which the metabolite extraction procedure
was followed by using MilliQ water instead of the sample of interest. These blanks take into
consideration contaminations (in e.g. solvents, derivatization reagents) and other problems thatmight
occur during the extraction or the derivatization step and should therefore always be monitored. In
addition, extraction blank information can be used for baseline substraction.
2. Internal Standards. Internal standards are ideally stable isotopically labelled compounds that
should be introduced in the sample processing as early as possible, (e.g. in the metabolite extraction
ﬂuid), and can be easily distinguished from endogenous metabolites by mass spectrometry. Ideally,
internal standards have the same substance class as the compounds present in the sample to be
analyzed and can therefore be used to correct for uncontrolled sample losses or compound
degradation and subsequent sample losses, to improve method precision and accuracy. As the whole
metabolite extraction and measurement procedure is performed with these internal standards, a
monitoring of losses due to various error sources is achieved.
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used to form a pool bymixing equal amounts within the experiment. The QC sample is then extracted
and inserted in the measurement sequence multiple times. We recommend extracting sufﬁcient QC
samples so that every 8th sample of the GC–MS run sequence is a pool sample. QC samples do not only
enable a monitoring of the GC–MS measurement quality, such as instrument drifts/sensitivity drops
and chromatographic changes (e.g. retention time shifts) but can also be used for data normalization [52_TD$DIFF]
[10]. In this case, normalization is done for each metabolite by dividing the sample metabolite
intensity by the average of the chronologically (within the sequence) nearest pool sample metabolite
intensities (Fig. 1 [53_TD$DIFF]). The main advantage of QC samples is that they contain the average of all
metabolites within all the samples that are analyzed which enables the monitoring of the
measurement quality for each individual metabolite even in non-targeted mode and for long
sequences. These QC samples serve as data normalization tool for untargeted metabolomics
approaches to remove analytical variation (see Section Statistical analysis) [54_TD$DIFF] 11]. This is in contrast to
the normalization by internal standardswhich is speciﬁc to the chemical classes similar to the internal
standards. Thereby, normalization by internal standards shows a better performance in a targeted
metabolomics analysis [55_TD$DIFF] 12]. In this protocol, we describe an untargeted metabolomics method and
thereby use QC normalization.
4. GC–MS sequence plan. A carefully planned measurement sequence should be set up for the
GC–MS run involving the samples, pools and blanks. We recommend to ﬁrst start with the
measurement of an alkanemix that can be used for further RI calibration, followed bya clean run (only
injecting MSTFA) without derivatization. Second, a blank should run followed by the samples. To
equilibrate the GC column for the matrix, 2–3 pool samples should be measured. We also recommend
that every 8th measurement is a pool sample. The samples should also be randomized within the
sequence and not follow a pre-deﬁned scheme which is very important for time-resolved
experiments.[(Fig._1)TD$FIG]
Fig.1. Normalization by reference poolmeasurements. In a GC–MS sequence plan, every 8th position a reference pool sample is
measured. For pool normalization, the average of the 2 nearest pools is calculated for each metabolite i (Xi ). Then, for each
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can occur. Therefore, instrument performance and robustness must be checked on regular intervals
during measurements. The performance check should ideally be performed by the monitoring of the
QC samples. In case of a sensitivity drop for the metabolites of interest within the QC samples, further
maintenance steps are required (e.g. column trimming, liner replacement).
Statistical analysis
After deconvolution and quantiﬁcation, the processed metabolomics data can be directly used for
statistical analysis with commercial or open-source software. The most important step of a statistical
analysis is data normalization to remove unwanted analytical variation and/or to correct for inter- and
intrabatch variability.
In this protocol, the metabolomics data is normalized by the generated reference pools (QC
samples) that have beenmeasured at every 8th position during the GC–MS run. To normalize by pools,
the following procedure has to be followed for each individual metabolite (Fig. 1):1. Calculate the average of the metabolite intensities of the chronologically 2 nearest pools
2. Divide the metabolite intensity of the sample of interest by the calculated average
Before statistical analysis, the GC–MSmeasurement andmetabolite extraction should be evaluated
by internal standards. Especially over long sequences, a decrease in sensitivity can be observed over
time. To monitor the decrease of sensitivity, internal standard signals can be observed over time and a
decision about the measurement quality can be made. In addition, samples that have not been
properly extracted can be identiﬁed as outliers by internal standard monitoring.
Whereas classical ANOVA or t-test methods are sufﬁcient for simple statistical comparisons, more
sophisticatedmethods are required to adequately analyse the very large amounts of data generated by
metabolomics technologies. A review of the use of machine learning algorithms in metabolomics has
recently been published [56_TD$DIFF] 13].
In this protocol, we provide an example of a supervised machine learning algorithm based on
logistic regression for sample classiﬁcation. The normalized data should be partitioned in training
and test set. The training set is used for the calculation of the model parameters by maximum
likelihood estimation and the test set is used for the evaluation of the model performance. The
model performance can be evaluated by receiver operating characteristics (ROC) curves enabling
the calculation of an optimal decision threshold for unknown sample identity predictions and the
respective speciﬁcity and sensitivity. After feature selection and model parameter calculation, the
logistic regression model can be used to predict the identities of unknown samples. The results are
stated as probabilities. As the learning algorithm tends to model noise instead of the desired
information, it is highly recommended to test the modeling process for overﬁtting. To avoid
overﬁtting, cross-validation and/or regularization of the model process are required [57_TD$DIFF] 14].
A detailed description of the modelling process and the corresponding R script written under R
version 3.2.2. using the “pROC” package [58_TD$DIFF] 15] and example ﬁles can be found in supplementary data
(Supplementary data 1–3).
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